BioLaw At BIO

Courtesy of a press pass generously awarded by the Biotechnology Industry Organization ("BIO"), BioLaw will be reporting from the 2007 BIO International Convention in Boston from May 6th-9th.

Every year the BIO meetings attract the global who's who of biotechnology to discuss what's what in the field. Almost 30,000 participants from around the globe will converge on Boston, the hometown of biotechnology, to present and discuss topics in the following 21 tracks: Bench to Products, Biopreparedness, Bioethics, Business Development, Clinical Research/Clinical Trials, Devices and Predictive Diagnostics, Doing Business Globally, Drug Discovery and Development, Emerging Company Issues, Finance, Food and Agriculture, Global Health, Industrial and Environmental, Intellectual Property/Legal, International Seminars, Manufacturing, Policy, Public Relations/Investor Relations, Regenerative Medicine, Regulatory, Technology Transfer/Licensing.

Watch this space for coverage of biolaw issues at BIO.